Synageva BioPharma Corp (NASDAQ:GEVA)

Delayed Data
As of May 22
 +2.32 / +1.08%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Synageva BioPharma Corp have a median target of 125.00, with a high estimate of 230.00 and a low estimate of 99.00. The median estimate represents a -42.69% decrease from the last price of 218.11.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in Synageva BioPharma Corp. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.51%
Growthannually -25.49%


Growthquarterly 31.74%
Growthannually 42.68%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account